Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001992324-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 10, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
24,672
Total Value
$885,889.28
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, CFO & CBO | Common Stock | โ | Apr 9, 2026 | Exercise/Conversion | 8,224 | $17.88 | $147,045.12 | 8,224 | Direct | โ | View Details | |
EVP, CFO & CBO | Common Stock | โ | Apr 9, 2026 | Sale | 8,224 | $89.84 | $738,844.16 | 0 | Direct | โ | View Details | |
EVP, CFO & CBO | Stock Option (Right to Buy) | Derivative | Apr 9, 2026 | Exercise/Conversion | 8,224 | $0.00 | $0.00 | 71,776 | Direct | โ | View Details |